2-(1-METHYLAZETIDIN-3-YL)ETHANAMINE, 95.0%, 250mg

TERT-BUTYL((1-METHOXYVINYL)OXY)DIMETHYLSILANE, 95.0%, 10g

(1R,2R)-(+)-1,2-Diphenylethylenediamine>98.0%(GC)(T)5g

Ethyl 2,3-difluoro-4-methoxybenzoate, 98%, 5g

5-Chloro-3-nitropicolinaldehyde, 95.0%, 100mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 1 – MWCO 6000–8000, 50 mm, 1 Piece(s)

3-(1-Methoxyethyl)aniline, 95%, 10g

5-Bromo-2-chloro-3-iodopyridine, 95.0%, 250mg

4-(Dimethylamino)benzonitrile>98.0%(GC)(T)5g

1,5-Dimethyl-2,4-bis[2-(trimethylsilyl)ethynyl]benzene>97.0%(GC)5g

1,3-Bis(bromomethyl)-5-methylbenzene, 95.0%, 250mg

2,3-Difluoro-4-ethoxybenzoic acid, 95.0%, 5g

17A-hydroxyprogesterone, 95.0%, 100g